Clinical trial
Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL…
NCT00300560 · Mahidol University, Other · Unknown status
Key facts
| NCT number | NCT00300560 |
|---|---|
| Title | Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli |
| Official title | Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli |
| Lead sponsor | Mahidol University, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections |
| Intervention type | Drug |
| Interventions | Colistin |
| Enrollment | 152 |
| Start date | Feb 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 9, 2006 |
| Last update posted | May 22, 2006 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: